ArticleBlood cancer journal2025
Talquetamab in relapsed refractory multiple myeloma: multi-institutional real-world study.
Samer Al Hadidi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this paperpooled itcites it